649 related articles for article (PubMed ID: 30607747)
1. Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Buijsen RAM; Toonen LJA; Gardiner SL; van Roon-Mom WMC
Neurotherapeutics; 2019 Apr; 16(2):263-286. PubMed ID: 30607747
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias.
Szpisjak L; Zadori D; Klivenyi P; Vecsei L
CNS Neurol Disord Drug Targets; 2019; 18(4):279-293. PubMed ID: 30864514
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
Karam A; Trottier Y
Adv Exp Med Biol; 2018; 1049():197-218. PubMed ID: 29427104
[TBL] [Abstract][Full Text] [Related]
4. Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias.
Afonso-Reis R; Afonso IT; Nóbrega C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921915
[TBL] [Abstract][Full Text] [Related]
5. AAV-Mediated CAG-Targeting Selectively Reduces Polyglutamine-Expanded Protein and Attenuates Disease Phenotypes in a Spinocerebellar Ataxia Mouse Model.
Niewiadomska-Cimicka A; Fievet L; Surdyka M; Jesion E; Keime C; Singer E; Eisenmann A; Kalinowska-Poska Z; Nguyen HHP; Fiszer A; Figiel M; Trottier Y
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673939
[TBL] [Abstract][Full Text] [Related]
6. Autosomal-dominant cerebellar ataxias.
Mundwiler A; Shakkottai VG
Handb Clin Neurol; 2018; 147():173-185. PubMed ID: 29325610
[TBL] [Abstract][Full Text] [Related]
7. Mini-review: spinocerebellar ataxias: an update of SCA genes.
Trott A; Houenou LJ
Recent Pat DNA Gene Seq; 2012 Aug; 6(2):115-21. PubMed ID: 22670601
[TBL] [Abstract][Full Text] [Related]
8. The clinical diagnosis of autosomal dominant spinocerebellar ataxias.
Klockgether T
Cerebellum; 2008; 7(2):101-5. PubMed ID: 18418679
[TBL] [Abstract][Full Text] [Related]
9. Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies.
Underwood BR; Rubinsztein DC
Cerebellum; 2008; 7(2):215-21. PubMed ID: 18418676
[TBL] [Abstract][Full Text] [Related]
10. Visual oculomotor abnormalities and vestibulo‑ocular reflex dynamics in polyglutamine spinocerebellar ataxias (Review).
Peng Y; Tu Q; Han Y; Wan C; Gao L
Exp Ther Med; 2023 Jul; 26(1):358. PubMed ID: 37324515
[TBL] [Abstract][Full Text] [Related]
11. Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion.
Niewiadomska-Cimicka A; Hache A; Trottier Y
Front Neurosci; 2020; 14():571. PubMed ID: 32581696
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies.
McIntosh CS; Li D; Wilton SD; Aung-Htut MT
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829728
[TBL] [Abstract][Full Text] [Related]
13. Spinocerebellar Ataxia Type 2.
Scoles DR; Pulst SM
Adv Exp Med Biol; 2018; 1049():175-195. PubMed ID: 29427103
[TBL] [Abstract][Full Text] [Related]
14. Polyglutamine spinocerebellar ataxias - from genes to potential treatments.
Paulson HL; Shakkottai VG; Clark HB; Orr HT
Nat Rev Neurosci; 2017 Oct; 18(10):613-626. PubMed ID: 28855740
[TBL] [Abstract][Full Text] [Related]
15. Gene Therapy for Polyglutamine Spinocerebellar Ataxias: Advances, Challenges, and Perspectives.
Vázquez-Mojena Y; León-Arcia K; González-Zaldivar Y; Rodríguez-Labrada R; Velázquez-Pérez L
Mov Disord; 2021 Dec; 36(12):2731-2744. PubMed ID: 34628681
[TBL] [Abstract][Full Text] [Related]
16. Widespread alternative splicing dysregulation occurs presymptomatically in CAG expansion spinocerebellar ataxias.
Shorrock HK; Lennon CD; Aliyeva A; Davey EE; DeMeo CC; Pritchard CE; Planco L; Velez JM; Mascorro-Huamancaja A; Shin DS; Cleary JD; Berglund JA
Brain; 2024 Feb; 147(2):486-504. PubMed ID: 37776516
[TBL] [Abstract][Full Text] [Related]
17. Verification of Inter-laboratorial Genotyping Consistency in the Molecular Diagnosis of Polyglutamine Spinocerebellar Ataxias.
Ramos A; Raposo M; Milà M; Bettencourt C; Houlden H; Cisneros B; Magaña JJ; Bettencourt BF; Bruges-Armas J; Santos C; Lima M
J Mol Neurosci; 2016 Jan; 58(1):83-7. PubMed ID: 26454745
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view.
Coarelli G; Brice A; Durr A
F1000Res; 2018; 7():. PubMed ID: 30473770
[No Abstract] [Full Text] [Related]
19. Cell biology of spinocerebellar ataxia.
Orr HT
J Cell Biol; 2012 Apr; 197(2):167-77. PubMed ID: 22508507
[TBL] [Abstract][Full Text] [Related]
20. Brain pathology of spinocerebellar ataxias.
Seidel K; Siswanto S; Brunt ER; den Dunnen W; Korf HW; Rüb U
Acta Neuropathol; 2012 Jul; 124(1):1-21. PubMed ID: 22684686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
